Big Moving Stock chart patterns and volume.

Nasdaq: GOOG NFLX BIIB AMZN IBB PCYC TSLA AMGN SLXP COST MNST WYNN GMCR AAPL MDVN VRTX CELG Z BMRN
Nyse: ACT V LNKD AGN PCP IVV GS SPG FDX MMM NOC PXD HUM IBM TWC APD BA BDX ANTM
New Highs: BIIB IBB PPG PCYC TWC DDS LH UHS AET CRI HSP VMC TGT HCA BMY HAIN CNC LAMR APH

The Hot Industries

Hospitals 2
Health Care Plans 2
Discount, Variety Stores 1

The Hot Sectors

Healthcare 9
Services 4
Technology 1

Social Buzz

AMRN is headed higher?

AMRN Stock ChartSimilar Stocks: ABBV AZN TEVA ACST GSK ISIS NEPT


AMRN
Analyze

Sector:

Healthcare
Daily

Industry:

Drug Manufacturers - Other
Weekly

Employees:

185
Monthly

Website:

http://www.amarincorp.com

AMRN Amarin Corporation plc

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

favicon

InPlay from Briefing.com

4 Mar 2015, 5:04 pmInPlay from Briefing.com
favicon

What's in Store for Geron (GERN) this Earnings Season? - Analyst Blog

2 Mar 2015, 11:00 amGeron Corporation (GERN) is set to report fourth quarter 2014 results on Mar 3 after the market closes.
favicon

Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog

28 Feb 2015, 6:01 pmIntercept Pharmaceuticals, Inc is slated to report its fourth-quarter 2014 results on Mar 2, 2015.
favicon

Will Endo Internationa's (ENDP) Beat on Earnings in Q4? - Analyst Blog

27 Feb 2015, 2:18 pmEndo International, Inc. (ENDP) is scheduled to report its fourth-quarter and full-year 2014 results on Mar 2, 2015.
favicon

Will Stratasys (SSYS) Disappoint this Earnings Season? - Analyst Blog

27 Feb 2015, 9:10 amStratasys Ltd. (SSYS) is set to report fourth-quarter 2014 results on Mar 2.
favicon

Should You Buy Amarin Corporation (AMRN) Ahead of Earnings? - Tale of the Tape

25 Feb 2015, 6:45 amAnalysts raising estimates right before earnings is a pretty good indicator of some favorable trends underneath the surface for Amarin Corporation.
favicon

What's in Store for OmniVision (OVTI) This Earnings? - Analyst Blog

24 Feb 2015, 10:40 amOmniVision Technologies, Inc. (OVTI) is set to report fiscal third-quarter 2015 results on Feb 26.
favicon

Can The Uptrend Continue for Amarin (AMRN)? - Tale of the Tape

23 Feb 2015, 7:13 amCan The Uptrend Continue for Amarin (AMRN)?
favicon

Amarin up on analyst upgrade

18 Feb 2015, 8:46 amLong-suffering bulls are finally getting some positive action from Amarin ( AMRN +13.6% ) after SunTrust Bank upgrades it to Buy from Neutral with a $6 price target.
favicon

Coverage of Biotech Equities -- Amarin, Cytori Therapeutics, Medivation, Sangamo BioSciences, and Immunomedics

5 Feb 2015, 7:27 amLONDON, February 5, 2015 /PRNewswire/ -- Investor-Edge has initiated coverage on the following equities: Amarin Corporation PLC (NASDAQ: AMRN), Cytori Therapeutics Inc. (NASDAQ: CYTX), Medivation Inc. (NASDAQ: MDVN), Sangamo BioSciences Inc. (NASDAQ: SGMO), and Immunomedics Inc. (NASDAQ:...